Europe Veterinary Ocular NSAIDs Market Share by Product Classification (2025)

Free

Percentage

Rising Generic Penetration to Drive Growth in Europe’s NSAIDs Veterinary Ocular Market

Published by MMR Statistics Reserch Team, November 2025

Growing clinical precision in animal ophthalmology is shaping the demand for specialised NSAID formulations across Europe. In 2024, the segment recorded steady advancements driven by the development of targeted anti-inflammatory therapies for companion animals. In 2025, the Europe NSAIDs Veterinary Ocular Market is estimated to display a balanced competitive structure, with generic veterinary products leading at 42.49%, followed by branded products at 39.56%. Compounded drugs contribute 10.71%, catering to specific treatment needs, while off-label human ocular drugs hold 7.24% of the total share.

OTHER STATISTICS ON TOPIC

Veterinary Ocular Medicine

More statistics on Veterinary Ocular Medicine

Related reports

Recommended and recent reports

Subscriptions

Stay ahead of Veterinary Ocular Medicine with tailored access

Sample free-tier statistics or unlock premium coverage for this topic with team-friendly usage rights.

Discover

Try free-tier statistics before committing to a plan.

Professional

Unlock premium coverage across this topic with analyst support.

Contact our team

Need a bespoke deep-dive on Veterinary Ocular Medicine?

Tell us about your KPIs and coverage priorities. We can tailor a briefing, share methodology notes, or build a custom dataset that complements the reports and statistics you are browsing.